Hpmc In Tablet
HPMC in Tablet – Precision-Engineered for Pharmaceutical Excellence
Deliver consistent potency, superior dissolution, and regulatory compliance with our high-purity HPMC tablets—custom-formulated to meet your exact specifications.
Expert Insight by David Chen
Technical Director | Tangzhi Technology (Hebei) Co., Ltd.
23 Years in Cellulose Chemistry | Former R&D Lead at BASF China
With two decades in cellulose chemistry and having led R&D teams at BASF China, I’ve witnessed firsthand how HPMC in tablet form revolutionizes pharmaceutical formulations. Today, as Technical Director at Tangzhi Technology, I oversee a team that transforms raw HPMC into high-performance tablet excipients—ensuring dissolution rates of 98%+ and zero batch variability. This page distills our expertise to help you select the right HPMC tablet solution for your next project.
What Is HPMC in Tablet Form?
Hydroxypropyl Methylcellulose (HPMC) is a semi-synthetic, inert polymer derived from cellulose. When compressed into tablet form, it serves as a multi-functional excipient with unparalleled versatility:
- Binder: Holds active pharmaceutical ingredients (APIs) together without compression issues.
- Disintegrant: Swells rapidly in contact with water, ensuring fast tablet breakdown for optimal bioavailability.
- Controlled Release: Tailored viscosity grades enable sustained or immediate-release profiles.
- Lubricant: Reduces friction during tableting, preventing sticking to punches.
- Film Former: Supports aqueous film coating for aesthetic and protective layers.
Why Tablets? Superior to Powders for Pharmaceutical Use
| Feature | HPMC Powder | HPMC Tablet |
|---|---|---|
| Dust Control | ❌ High airborne dust risk | ✅ Dust-free, safer handling |
| Flowability | ⚠️ Poor flow, requires glidants | ✅ Excellent flow, consistent dosing |
| Compression Stability | ⚠️ Variable hardness, capping issues | ✅ Uniform hardness, no capping |
| Hygroscopicity | ⚠️ Absorbs moisture, clumping | ✅ Coated tablets resist moisture |
| Regulatory Compliance | ❌ Additional excipients needed | ✅ Fewer ingredients = cleaner filings |
Key Performance Metrics of HPMC Tablets
Our HPMC tablets are engineered to exceed pharmaceutical-grade standards:
- Disintegration Time: ≤15 minutes (vs. 20-30 min for powder blends)
- Dissolution Rate: ≥98% in 30 minutes (USP/EP compliant)
- Tablet Hardness: 100-150 N (optimal for packaging and handling)
- Moisture Content: ≤3% (ensures stability in tropical climates)
- Heavy Metals: ≤10 ppm (meets ICH Q3D guidelines)
Market Opportunity: Why HPMC Tablets Are a Strategic Investment
The global pharmaceutical excipients market is projected to reach $11.2 billion by 2027 (CAGR 5.8%), driven by:
- Oral Solid Dosage Growth: 72% of new drug formulations are tablets/capsules (IQVIA, 2026).
- Generic Drug Expansion: 80% of prescriptions in the US are generics, requiring cost-efficient excipients.
- Regulatory Tightening: FDA/EMA mandating reduced use of synthetic binders like PVP.
- APAC Demand: Southeast Asia’s oral solid dosage market growing at 8.3% CAGR (Frost & Sullivan).
Pain Points Translating to Opportunity
Pharma formulators face three critical bottlenecks that HPMC tablets solve:
- Cost Overruns: Traditional binders (e.g., lactose) add 30-50% to raw material costs. HPMC offers a 20% cost saving with superior performance.
- Supply Chain Fragility: 68% of pharma companies report dependency risks from single-source suppliers (McKinsey, 2022). Tangzhi’s multi-sourced cellulose mitigates this.
- Regulatory Scrutiny: HPMC’s GRAS status (FDA 21CFR172.874) reduces filing burdens vs. novel excipients.
“HPMC tablets cut our disintegration time by 40% and eliminated moisture-related batch rejections.”
—Dr. Li Wei, R&D Director at GenericPharm Inc. (Singapore)
Consumer Insights: What Formulators Really Want
After analyzing feedback from 127 pharma formulators across USA, Europe, and APAC (via industry webinars and site visits), we distilled these non-negotiable pain points:
- “We need zero variability.” Batch-to-batch consistency is critical for blend uniformity and regulatory audits.
- “Dust is killing us.” Airborne HPMC powder leads to cross-contamination and worker safety risks.
- “Our tablets are cracking.” Poor compression properties cause tablet capping and rejected batches.
- “We can’t afford delays.” Supply chain disruptions during high-demand periods halt production.
- “We need global compliance.” Multi-market filings require excipients with USP/EP/JP monographs.
Real-World Pain Point Examples
- EU Formulator: “Our HPMC powder had 8% moisture variability → tablets failed dissolution tests in Germany.”
- US CMO: “Dust from powder HPMC contaminated our cleanroom → FDA 483 warning.”
- APAC Generic Maker: “Capping issues led to 15% yield loss → contract penalties with Big Pharma.”
Product Capability: Custom HPMC Tablets Tailored to Your Needs
Tangzhi Technology’s HPMC tablets are engineered to your exact formulation. Below is our modular customization matrix:
| Customization Parameter | Options | Differentiated Advantage |
|---|---|---|
| Viscosity Grade | 5cP, 15cP, 40cP, 100cP | Choose viscosity to match release profile (immediate vs. extended). |
| Hydroxypropyl Content | 4%, 7%, 9%, 12% | Higher % = faster disintegration but lower hardness. |
| Tablet Shape | Round, Caplet, Oval, Custom | Custom molds for brand differentiation. |
| Coating | Uncoated, HPMC Film, Enteric | Film coating enables taste masking and moisture resistance. |
| API Compatibility | Acidic, Basic, Neutral APIs | No interaction with APIs → zero formulation conflicts. |
| Release Profile | Immediate, Extended, Pulsatile | Engineered for zero-order kinetics. |
| Regulatory Filings | USP, EP, JP, DMF-ready | Accelerates regulatory approvals for generics. |
“Tangzhi’s HPMC tablets gave us 99.5% disintegration in 12 minutes—critical for our fast-dissolving generic.”
—Sophie Müller, Formulation Chemist at MedTech GmbH (Germany)
Why Us? Building Trust Through Capability and Transparency
🏭 Factory & Capacity: Scale Without Compromise
cas-9004-62-0 hpmc-full-form-in-pharmacy antifreeze-in-concrete hpmc-e15
Facility: 140,000 m² factory with GMP-certified production lines.
Annual Capacity: 40,000 tons of HPMC (expandable to 60,000 tons).
Automation: Fully robotic packaging and palletizing (reduces human error by 90%).
📜 Certifications: Global Compliance, Local Trust
🔗 Supply Chain: Multi-Sourced Resilience
We source cellulose from 3 certified suppliers (Brazil, Indonesia, China) to mitigate geopolitical risks. Our just-in-time inventory ensures:
- Lead Time: 14 days (vs. 21-28 days for competitors).
- MOQ: 500 kg (ideal for pilot batches).
- Flexible Scheduling: Dedicated slots for rush orders.
🏆 Success Stories: Proven in the Field
“Tangzhi’s HPMC tablets reduced our disintegration time from 25 to 10 minutes—critical for our OTC launch.”
—Carlos Rodriguez, Operations Director at SaludPharm (Mexico)
“Their DMF filing support cut our ANDA submission time by 6 months.”
—Emma Johansson, Regulatory Affairs at NordicPharma (Sweden)
Collaboration Process: From Inquiry to Delivery in 4 Simple Steps
Our streamlined process eliminates uncertainty and accelerates your time-to-market:
Prototyping (3-5 Days)
Submit your formulation → We provide 3 prototype blends with varying viscosity/hydroxypropyl content.

Scale-Up Production (7-10 Days)
Finalize specs → 100 kg pilot batch with full QC testing.
Quality Inspection (5 Days)
Batch tested for USP/EP compliance → Certificate of Analysis issued.
Global Delivery (14 Days)
Palletized, fumigated, and shipped via DHL/FedEx with real-time tracking.
FAQs: Your Top Questions Answered
1. Can HPMC tablets replace multiple excipients in my formula?
Yes. A single HPMC tablet can act as binder, disintegrant, lubricant, and film former—reducing your excipient count by up to 40%.
2. What’s the moisture resistance of your coated tablets?
98% moisture resistance at 85% RH/30°C for 3 months (tested per ICH Q1A).
3. Do you offer OEM/ODM tablet shapes?
Yes. We provide custom molds for brand-specific shapes (e.g., heart, oval) with no MOQ.
4. What’s your minimum order quantity (MOQ)?
500 kg (ideal for pilot batches). For larger orders, we offer volume discounts.
5. Can you support DMF filings?
Yes. We provide full DMF Type IV support with confidential data packages.
6. How do you ensure batch-to-batch consistency?
Our automated QC system performs 20+ tests per batch (viscosity, hydroxypropyl content, particle size, moisture).
7. What’s your lead time for rush orders?
14 days for standard orders, 7 days for rush orders (subject to capacity).
Ready to Transform Your Formulation?
Join 200+ pharma clients who’ve upgraded to HPMC tablets for faster disintegration, lower costs, and zero dust risks.
Limited-time offer: First 50 inquiries receive a free DMF filing template.
Contact Us for a Custom Solution
Prefer a call? Book a 15-minute consultation with our Technical Director: